Vincent S LoPriore, Executive Chairman at Hepion Pharmaceuticals, bought HEPA on Aug 3, 2026
Data as of Oct 16
▲ BUY$400K8,000,000 shares at $0.05Vincent S LoPriore Executive ChairmanHEPA Hepion Pharmaceuticals, Inc.
- Traded
- Aug 3, 2026
- Disclosed
- Aug 12, 2026
- Filed
- 9 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
HEPA since disclosure
+103.1%
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund
Change in closing price from Aug 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
- Not enough evidence · In past tests: 8.0 percentage points better than similar stocks over 3 months · 2,952 tries
Other trades in the same filing
- ▲ BUYVincent S LoPriore Executive ChairmanHEPA Hepion Pharmaceuticals, Inc.$100Kdisclosed Aug 12 · filed 9 days after the trade · late 1 rule fired